Probiotics for babies and children: nourishing the best start in life

Pediatric health

Pediatric probiotics support gut microbiome development during the first 1,000 days of life. We offer strains clinically studied in the pediatric population, from infancy onward.

Pediatric Health

Supporting the first 1,000 days of life for healthy development

The diversity of the gut microbiome and its functions begins in early infancy – with bacterial colonization playing a critical role in gut maturation, as well as metabolic, immune and brain development during the first 1,000 days of life.1,2,3

A healthy baby first establishes a low-diversity gut microbiome dominated by Bifidobacteria. Having the right balance of Bifidobacterium strains in the infant gut plays an especially important role in immunity. However, during the first 1,000 days of life the gut microbiome is influenced by several factors, including whether a baby is born by cesarean, bottle fed or exposed to antibiotics – which can decrease concentrations of protective Bifidobacteria in the gut. This can create challenges, including a higher risk of colic or allergies in babies.

Selected probiotics can help enrich the gut microbiome in babies – fostering healthy microbiota development and restoration. We offer and characterize a range of specially designed probiotic blends to support infants.

Probiotic solutions for Pediatric health

KABP® Kolicare

1 billion CFU/dose

A trusted probiotic for infants, from the first days of life. KABP® Kolicare is clinically studied and carefully formulated to support infant well-being from birth.

Indications and benefits

  • Baby colic
  • Supports healthier microflora balance, which is correlated with decreased crying time in colicky infants
  • Helps reduce the duration of crying episodes
  • Supports family quality of life, due to greater gut comfort
  • Promotes beneficial gut microflora
  • Custom formulations available

Strains

  • B. longum KABP® 042
  • P. pentosaceus KABP® 041

Formats

Drops

Frequently Asked Questions about Pediatric health

Do you have other questions? Just get in touch and our team will assist you.

Yes, when the probiotic strains are clinically studied in the intended pediatric population, appropriately dosed for the relevant age group, and supported by safety documentation suited to infant or children’s product development. Probiotics are not a category where adult evidence transfers directly to pediatric applications.

For parents and caregivers considering probiotic supplementation for infants, premature, or immunocompromised, or young children, consult a pediatrician before introducing any new supplement.

Specific, clinically studied probiotic strains have demonstrated evidence for colic support in infants, particularly through their ability to enrich the gut microbiome with beneficial Bifidobacteria, restore microflora balance, and reduce the duration of crying episodes associated with infant colic. The mechanism is closely tied to gut microbiota composition: infants with colic often show lower levels of protective bacteria, and targeted probiotic supplementation may help address that underlying imbalance.

KABP® Kolicare is Kaneka Probiotics’ purpose-built infant colic formulation, combining B. longum KABP® 042 and P. pentosaceus KABP® 041 and supported by 10 clinical studies.

For parents navigating infant colic, a pediatrician is the best resource for guidance on whether probiotic supplementation is appropriate for their child’s specific situation.

Drops are the most clinically established and commercially appropriate format for infant probiotic supplements, particularly for infants in the first year of life. Drops allow for precise dosing, straightforward administration directly into the infant’s mouth or into a bottle, and are the format used across the majority of clinical trials studying probiotics in this population.

KABP® Kolicare is available in drops, reflecting both clinical precedent and the practical realities of administering supplements to infants. As children develop, the appropriate format options expand: powders and dissolvable sachets become viable for toddlers, while chewable formats are suitable for older children as palatability, compliance, and swallowing ability allow.

  1. Martin, R. et al. Early-Life Events, Including Mode of Delivery and Type of Feeding, Siblings and Gender, Shape the Developing Gut Microbiota. PLoS One 11, e0158498 (2016)
  2. Kato, K. et al. Age-Related Changes in the Composition of Gut Bifidobacterium Species. Curr. Microbiol. 74, 987–995 (2017)
  3. Avershina, E. et al. Bifidobacterial succession and correlation networks in a large unselected cohort of mothers and their children. Appl. Environ. Microbiol. 79, 497–507 (2013)

Request our Product Catalogue by filling out the form below

Would you like to know more about our products?